Justin Kaner, Assistant Professor of the Leukemia Program at Weill Cornell, shared on X:
“To transplant or not to transplant…..
Evolving story on NPM/FLT3-ITD acute myeloid leukemia, If MRD- Postinduction molecular MRD identifies patients with NPM1 AML who benefit from allo SCT in CR1.” .
Read further.
Source: Justin Kaner/X